scholarly article | Q13442814 |
P356 | DOI | 10.1007/S12519-018-0125-Y |
P698 | PubMed publication ID | 29532435 |
P2093 | author name string | Jian-Hua Mao | |
Fei Liu | |||
P2860 | cites work | A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase | Q24296311 |
Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin | Q24338951 | ||
The cyclophilins | Q24812580 | ||
Use of Cyclosporine Therapy in Steroid Resistant Nephrotic Syndrome (SRNS): A Review | Q26827717 | ||
The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun | Q28263918 | ||
Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins | Q29618460 | ||
Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation | Q29620223 | ||
Tacrolimus-associated hemolytic uremic syndrome: a case analysis. | Q33358357 | ||
De novo thrombotic microangiopathy. An underrated complication of renal transplantation | Q33375722 | ||
Tacrolimus withdrawal and conversion to sirolimus at three months post-pediatric renal transplantation | Q33378678 | ||
Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. | Q34181871 | ||
Chronic allograft nephropathy: current concepts and future directions | Q34501818 | ||
Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children | Q34659232 | ||
Basigin/CD147 promotes renal fibrosis after unilateral ureteral obstruction | Q34755789 | ||
Calcineurin inhibitor nephrotoxicity | Q34945314 | ||
Cyclosporine A-induced renal fibrosis: a role for epithelial-mesenchymal transition. | Q35085117 | ||
Transplantation: toxicokinetics and mechanisms of toxicity of cyclosporine and macrolides. | Q35647093 | ||
Independent risk factors for chronic cyclosporine induced nephropathy in children with nephrotic syndrome | Q36153584 | ||
New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone. | Q36788871 | ||
Experience with tacrolimus in children with steroid-resistant nephrotic syndrome | Q37229944 | ||
Calcineurin-inhibitor free immunosuppression with mycophenolate mofetil and corticosteroids in paediatric renal transplantation improves renal allograft function without increasing acute rejection | Q37320783 | ||
Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option? | Q37821472 | ||
Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence | Q38116657 | ||
Is it time to give up with calcineurin inhibitors in kidney transplantation? | Q38156847 | ||
Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children. | Q38569641 | ||
The over-exaggerated chronic nephrotoxicity of calcineurin inhibitors | Q38630386 | ||
Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras | Q39680835 | ||
Suppression of NF-kappaB by cyclosporin a and tacrolimus (FK506) via induction of the C/EBP family: implication for unfolded protein response | Q39849371 | ||
Response of human renal tubular cells to cyclosporine and sirolimus: a toxicogenomic study | Q40115041 | ||
Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 | ||
A novel, semiquantitative, clinically correlated calcineurin inhibitor toxicity score for renal allograft biopsies | Q40182802 | ||
Renal Graft Fibrosis and Inflammation Quantification by an Automated Fourier-Transform Infrared Imaging Technique | Q40338749 | ||
Proximal Tubular Injury in Medullary Rays Is an Early Sign of Acute Tacrolimus Nephrotoxicity | Q40709714 | ||
Clinical efficacy and pharmacokinetics of tacrolimus in children with steroid-resistant nephrotic syndrome | Q40775615 | ||
Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy | Q41184484 | ||
Second-line options for refractory steroid-sensitive and -resistant nephrotic syndrome | Q42723614 | ||
Introduction of mycophenolate mofetil and cyclosporin reduction in children with chronic transplant nephropathy | Q43687552 | ||
Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity | Q44213050 | ||
Renal interstitial fibrosis in children treated with FK506 for nephrotic syndrome | Q44853317 | ||
Cyclosporine A attenuates the natriuretic action of loop diuretics by inhibition of renal COX-2 expression. | Q44900413 | ||
Patient selection critical for calcineurin inhibitor withdrawal in pediatric kidney transplantation | Q46531742 | ||
Computerized image analysis of Sirius Red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function | Q46908569 | ||
Molecular comparison of calcineurin inhibitor-induced fibrogenic responses in protocol renal transplant biopsies | Q46935290 | ||
Sirolimus in chronic allograft nephropathy in pediatric recipients | Q46970910 | ||
Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A | Q46979889 | ||
CYP3A5 Genotype and Time to Reach Tacrolimus Therapeutic Levels in Renal Transplant Children. | Q50905464 | ||
Tacrolimus for children with refractory nephrotic syndrome: a one-year prospective, multicenter, and open-label study of Tacrobell®, a generic formula. | Q51292313 | ||
Effect of adding Mycophenolate mofetil in paediatric renal transplant recipients with chronical cyclosporine nephrotoxicity. | Q52970451 | ||
Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. | Q53360030 | ||
Effect of cyclosporine administration on renal hemodynamics in conscious rats. | Q54441851 | ||
Maintenance Immunosuppression With Mycophenolate Mofetil and Corticosteroids in Pediatric Kidney Transplantation: Temporary Benefit but Not Without Risk | Q59564426 | ||
Risk Factors for Early Epithelial to Mesenchymal Transition in Renal Grafts | Q61859683 | ||
Safety and Efficacy of a Calcineurin Inhibitor Avoidance Regimen in Pediatric Renal Transplantation | Q63244404 | ||
Glomerulotubular function in cyclosporine-treated rats. A lithium clearance, occlusion time/transit time and micropuncture study | Q70096014 | ||
Cyclosporine-associated chronic nephropathy | Q70376376 | ||
Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy | Q73683739 | ||
The side-effects of ciclosporine-A and tacrolimus | Q77059728 | ||
Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group | Q77781312 | ||
Computerized histomorphometric assessment of protocol renal transplant biopsy specimens for surrogate markers of chronic rejection | Q78106839 | ||
Management of steroid-resistant focal segmental glomerulosclerosis in children using tacrolimus | Q79422909 | ||
SRL-based immunosuppression vs. CNI minimization in pediatric renal transplant recipients with chronic CNI nephrotoxicity | Q79953119 | ||
Early experience with conversion to sirolimus in a pediatric renal transplant population | Q80727373 | ||
Conversion from calcineurin inhibitor to sirolimus in pediatric chronic allograft nephropathy | Q83377108 | ||
Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome | Q84415164 | ||
Histological characteristics of calcineurin inhibitor toxicity--there is no such thing as specificity! | Q84870341 | ||
Serum levels and activity of indoleamine2,3-dioxygenase and tryptophanyl-tRNA synthetase and their association with disease severity in patients with chronic kidney disease | Q86731520 | ||
P433 | issue | 2 | |
P304 | page(s) | 121-126 | |
P577 | publication date | 2018-03-12 | |
P1433 | published in | World Journal of Pediatrics | Q15763275 |
P1476 | title | Calcineurin inhibitors and nephrotoxicity in children. | |
P478 | volume | 14 |
Q55515010 | Longitudinal Study of the Role of Epidermal Growth Factor on the Fractional Excretion of Magnesium in Children: Effect of Calcineurin Inhibitors. | cites work | P2860 |
Search more.